Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Oral vitamin could be key to lowering risk of some skin cancers
TIM PALMER.
Amgen’s Imlygic cancer drug recommended for approval in Europe
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion recommending approval for Amgen's Imlygic drug to treat melanoma.
Roche delivers strong sales growth in the first nine months of 2015
Sales of the Roche Group increased 6% to CHF 35.
New drug approved for soft-tissue cancer
(HealthDay)—The chemotherapy drug Yondelis (trabectedin) has been approved by the U.
Genentech advances second Nav1.7 inhibitor for pain into clinical development
Xenon Pharmaceuticals' partner Genentech, a member of the Roche Group, has advanced a second Nav1.
Competitor undercuts hedge fund bro by selling AIDS drug for $1 a pill
A former uber-capitalist hedge manager who gouged the price of an AIDS drug because he could is about to have his own business gouged, courtesy of the free market.
Early Parkinson's diagnosis may be possible using skin odour
A study has been launched to identify small molecules secreted by the skin that are believed to emit a subtle but unique scent in people in the early stages of Parkinson’s.
FDA Approves Onivyde (irinotecan liposome injection) for Advanced Pancreatic Cancer
October 22, 2015 -- The U.
FDA Approves Enstilar Foam
Ballerup, Denmark 19 October, 2015.
Relypsa wins patiromer OK but gets hammered on black box restrictions
After a long and expensive clinical journey, Relypsa ($RLYP) won FDA approval to commercialize patiromer--to be sold as Veltassa--for hyperkalemia.
2015 FDA Approved Drugs
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States.
Is 2016 the Year for Immunotherapy? Predictions on a Buzz-Worthy Field
Immunotherapy is touted more and more as the future of cancer treatment.
644
645
646
647
648
649
650
651
652
